Previous close | 110.00 |
Open | 110.00 |
Bid | 129.30 |
Ask | 135.20 |
Strike | 300.00 |
Expiry date | 2025-01-17 |
Day's range | 110.00 - 110.00 |
Contract range | N/A |
Volume | |
Open interest | 25 |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
The S&P 500 was quiet again, but Toast led several new buys. Robinhood and Arm were big earnings movers late.